|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0125 - 0.0137|
|52 Week Range||0.0010 - 0.2800|
|Beta (5Y Monthly)||5.16|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 17, 2016|
|1y Target Est||N/A|
VANCOUVER, BC , June 22, 2020 /CNW/ - Invictus MD Strategies Corp. (GENE-H.V) (the "Company") announced today that it has entered into an investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage"). The purchaser is Acreage Developments Corp. (the "Investor"), a privately-owned company that is unrelated to the Company and its directors and officers. Completion of the sale is subject to condition precedents including Court approval of the transaction and a plan of compromise and arrangement (the "Plan") being approved by the creditors of Acreage and the Court in the CCAA proceedings currently underway involving the Company and its subsidiaries.
The Company wishes to thank Ms. Toor for her service. The Company's Controller, Ms. Elena Gershtein has been appointed Acting CFO. Elena has a Bachelor of Commerce Degree in Accountancy from the University of British Columbia .